A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : 2-AG / 2-arachidonoylglycerol

[Related PubMed/MEDLINE]
Total Number of Papers: 1382
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   2-AG  (>> Co-occurring Abbreviation)
Long Form:   2-arachidonoylglycerol
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator. DNBS, GLUPEA, MCP-2, PEA, TRPV1
2021 Activation of TRPV1 by Capsaicin or Heat Drives Changes in 2-Acyl Glycerols and N-Acyl Ethanolamines in a Time, Dose, and Temperature Dependent Manner. eCBs, NAEs, TRP
2021 Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. ASD, eCB, VPA
2021 Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB1 Receptor Activation. Ang II
2021 Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase. AEA, FAAH, MAGL
2021 BIONOTE as an Innovative Biosensor for Measuring Endocannabinoid Levels. eCBs
2021 Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors. AEA, CB1R, CESD-R, eCB
2021 Circulating fatty acids and endocannabinoidome-related mediator profiles associated to human longevity. 2-LG, 2-OG, AEA, CLA, DHA, DHEA, eCBome, HLZ, LLZ, OEA, POA
2021 Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening. AA, MAGL, MAGs
10  2021 Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids. AEA, DHEA, EPA, EPEA, FA, LC n-3 PUFAs, PLA2G2D, PLA2G4A, scWAT, WAT
11  2021 Effects of R-flurbiprofen and the oxygenated metabolites of endocannabinoids in inflammatory pain mice models. AEA, COX, LPS, NSAIDs, PGs
12  2021 Endocannabinoid reactivity to acute stress: Investigation of the relationship between salivary and plasma levels. AEA, eCB
13  2021 Endocannabinoids Attenuate the Virulence of Certain Enteropathogenic Bacteria. ---
14  2021 Endocannabinoids increase human adipose stem cell differentiation and growth factor secretion in vitro. AEA, ASCs, ECS, ELISA
15  2021 Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans. AEA, eCBs, NAL, PLA, RUN, WALK
16  2021 Exploring the Utility of Hair Endocannabinoids for Monitoring Homeostasis in Bonobos. AEA, EC, OEA, SEA
17  2021 Genetic Manipulation of sn-1-Diacylglycerol Lipase and CB1 Cannabinoid Receptor Gain-of-Function Uncover Neuronal 2-Linoleoyl Glycerol Signaling in Drosophila melanogaster. 2-LG, CB1R, DAGL
18  2021 Human laryngeal squamous cell carcinoma cell line release of endogenous anandamide and 2-arachidonoylglycerol, and their antiproliferative effect via exogenous supplementation: an in vitro study. AEA, LSCC
19  2021 Impact of saffron (Crocus Sativus Linn) supplementation and resistance training on markers implicated in depression and happiness levels in untrained young males. 1RM, AEA, RP, RS, RT
20  2021 In situ localization of diacylglycerol lipase α and β producing an endocannabinoid 2-arachidonoylglycerol and of cannabinoid receptor 1 in the primary oocytes of postnatal mice. CB1, DGL, eCB
21  2021 Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss. MAGL, MAPK, NF-kappaB
22  2021 Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease. AD, MAGL
23  2021 Inhibition of CB1 receptor alleviates electroconvulsive shock-induced memory impairment by regulating hippocampal synaptic plasticity in depressive rats. CB1R, CMS, ECS, ECT, LTP, OFT, SPT
24  2021 Inverse correlation between plasma 2-arachidonoylglycerol levels and subjective severity of depression. MDD
25  2021 Modulation of single cell circadian response to NMDA by diacylglycerol lipase inhibition reveals a role of endocannabinoids in light entrainment of the suprachiasmatic nucleus. ECs, NMDA, SCN
26  2021 Molecular cloning and characterization of an atypical butyrylcholinesterase-like protein in zebrafish. ACh, BChE, OP
27  2021 Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome. eCBome
28  2021 Neurochemical mechanisms and neurocircuitry underlying the contribution of stress to cocaine seeking. CRF, VTA
29  2021 Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice. CB1R, CLEM, D2R, DA, LH, NAc, Ox-A, OX1R, PLC, VTA, WT
30  2021 Oxygenation of endocannabinoids by mammalian lipoxygenase isoforms. ANA
31  2021 Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder. AEA, eCB, MDD, rTMS
32  2021 Selective inhibition of monoacylglycerol lipase is associated with passive coping behavior and attenuation of stress-induced dopamine release in the medial prefrontal cortex. AEA, DA, EPM, FAAH, FST, LDT, MAGL, mPFC, TST
33  2021 Targeting 2-arachidonoylglycerol (2-AG) signalling the neurobiology and treatment of depression. MAGL, MDD
34  2021 The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice. CB1R, FAAH, MAGL
35  2021 The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area. AEA, AEA, qRT-PCR, VTA
36  2021 The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity. ABHD6, MAGL, PI3K
37  2021 The endocannabinoid system in the adipose organ. ---
38  2021 The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB1 Cannabinoid Receptor. MAGL, TIMP-1
39  2021 Untapped endocannabinoid pharmacological targets: pipe dream or pipeline? ABHD6, DAGL-beta, DAGLalpha, FAAH, MAGL
40  2020 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics. MAGL
41  2020 2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions. CSPGs, MS, OPC
42  2020 A micro salting-out assisted liquid-liquid extraction combined with ultra-high performance liquid chromatography tandem mass spectrometry to determine anandamide and 2-arachidonoylglycerol in rat brain samples. AEA, PD
43  2020 A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing. HT, OEA, PEA
44  2020 A simple LC-MS/MS method for the simultaneous quantification of endocannabinoids in biological samples. EC, FDA, NADA
45  2020 ABHD11, a new diacylglycerol lipase involved in weight gain regulation. ABHD11, DIO
46  2020 Allosteric modulation of adenosine A1 and cannabinoid 1 receptor signaling by G-peptides. CB1, NECA, SPASM, WN
47  2020 Alterations of brain endocannabinoidome signaling in germ-free mice. AEA, eCB, eCBome, FMT, GF, NAEs
48  2020 Altered productions of prostaglandins and prostamides by human amnion in response to infectious and inflammatory stimuli identified by mutliplex mass spectrometry. AEA, PGE2
49  2020 An inverse agonist of estrogen-related receptor γ regulates 2-arachidonoylglycerol synthesis by modulating diacylglycerol lipase expression in alcohol-intoxicated mice. ACEA, CB1R, DAGL, ERRgamma, WT
50  2020 An optimized spectrophotometric assay reveals increased activity of enzymes involved in 2-arachidonoyl glycerol turnover in the cerebral cortex of a rat model of Alzheimer's disease. 4-NPB, AD, DAGLalpha, MAGL
51  2020 Anandamide prevents the adhesion of filamentous Candida albicans to cervical epithelial cells. AEA, AraS
52  2020 Associating Emergency Medical Services personnel's workload, trauma exposure, and health with the cortisol, endocannabinoid, and N-acylethanolamine concentrations in their hair. AEA, EMS, HPA, OEA, PEA, SEA
53  2020 Attenuation of fear-conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: Potential role for CB2 receptors. ACC, FCA, MGL
54  2020 Bioconjugation of 2-arachidonoyl glycerol (2-AG) biotinylated antibody with gold nano-flowers toward immunosensing of 2-AG in human plasma samples: A novel immuno-platform for the screening of immunomodulation and neuroprotection using biosensing. DLS, FESEM, LLOQ, TEM
55  2020 Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear. i.p, MGL, TMT
56  2020 Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells. CB1, CB2
57  2020 Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Abeta1-42 peptide in rat hippocampal neurons. AD, AEA, ECS, FAAH, ROS
58  2020 Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2. CB1R, CB2R, eCB, ERG, OPs
59  2020 Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome. AA, ADHD, CSF, ECS, LC/MRM, OCD, PEA, THC, dronabinol, TS
60  2020 Characterization of a monoacylglycerol lipase in the medicinal leech, Hirudo verbana. HirMAGL, MAGL
61  2020 Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice. ECS, ECs, NAEs, OEA
62  2020 Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults. 2-OG, BMI, eCB
63  2020 Circulating endocannabinoid concentrations in grieving adults. AEA, ECS, HC
64  2020 Circulating Endocannabinoids and Mortality in Hemodialysis Patients. AEA, eCB, ESRD, HR, MHD
65  2020 Combatting joint pain and inflammation by dual inhibition of monoacylglycerol lipase and cyclooxygenase-2 in a rat model of osteoarthritis. COX-2, CXB, MAGL, MIA, OA
66  2020 Comparison of endocannabinoids levels, FAAH gene polymorphisms, and appetite regulatory substances in women with and without binge eating disorder: a cross- sectional study. AEA, BED, FAAH
67  2020 Components of Endocannabinoid Signaling System Are Expressed in the Perinatal Mouse Cerebellum and Required for Its Normal Development. CB1, CB1KO, eCB
68  2020 COX-2 Inhibition Antagonizes Intra-Accumbens 2-Arachidonoylglycerol-Mediated Reduction in Ethanol Self-Administration in Rats. COX-2, EtOH, NAc
69  2020 Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats. THC
70  2020 CSF Levels of the Endocannabinoid Anandamide are Reduced in Patients with Untreated Narcolepsy Type 1: A Pilot Study. AEA, ECs, NT1
71  2020 Design, microwave-assisted synthesis, biological evaluation and molecular modeling studies of 4-phenylthiazoles as potent fatty acid amide hydrolase inhibitors. AEA, FAAH
72  2020 Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. MAGL
73  2020 Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors. DAGLA, eCB
74  2020 Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat. AEA, FA, NAEs, OEA
75  2020 Differential effect of interferon-alpha treatment on AEA and 2-AG levels. AEA, eCB, eCBs, End, FU, HCV, IFN-alpha, IL, TW
76  2020 Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in paracetamol-induced liver injury. DILI, gammaGT
77  2020 Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study. MAGL
78  2020 Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms. AEA, EC, ET, HC, MF, MPN, NAE, OEA, PEA, PV
79  2020 Dopamine D1 receptor signaling and endocannabinoid cooperate to fuel striatal plasticity: An Editorial Highlight for "Cyclic AMP-dependent protein kinase and D1 dopamine receptors regulate diacylglycerol lipase-alpha and synaptic 2-arachidonoyl glycerol signaling" on page 334. DGL, eCBs, MSN, PKA, Ser
80  2020 Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease. AD, aPKC, ARA, Mgll, NPC
81  2020 Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model. CB1, CB2, i.p, MAGL, WAS
82  2020 Effects of a High-Protein Diet on Cardiometabolic Health, Vascular Function, and Endocannabinoids-A PREVIEW Study. AEA, BMI, BP, CVD, HP, HR, LDL, MP, OEA, PEA, PREG, TC
83  2020 Electronic-Cigarette Vehicles and Flavoring Affect Lung Function and Immune Responses in a Murine Model. 12-HETE, e-cigs, ENDS, EVALI, PG, VG
84  2020 Endocannabinoid concentrations in hair and mental health of unaccompanied refugee minors. AEA, EC, OEA, PEA, SEA, TLE
85  2020 Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes. AA, eCB, GPCR, LPA, MAGs, UFAs
86  2020 Endocannabinoid levels in patients with Parkinson's disease with and without levodopa-induced dyskinesias. AEA, LID, PD
87  2020 Endocannabinoid LTD in Accumbal D1 Neurons Mediates Reward-Seeking Behavior. eCB, LTD, mGluR5, MSNs, NAc
88  2020 Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance. DA, eCBs
89  2020 Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening. BLA, dmPFC
90  2020 Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice. MAGL
91  2020 Endocannabinoid system alterations in Alzheimer's disease: A systematic review of human studies. AD, AEA, ECS, FAAH, MAGL, MCI, TRPV1
92  2020 Endocannabinoid system and cardiometabolic risk factors: A comprehensive systematic review insight into the mechanistic effects of omega-3 fatty acids. AEA
93  2020 Endocannabinoid-Epigenetic Cross-Talk: A Bridge toward Stress Coping. CB1, ECS
94  2020 Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis. 2-OG, AEA, ALS, eCB, OEA, PEA
95  2020 Endocannabinoids and Stroke Prevention: Review of Clinical Studies. AEA, ECS
96  2020 Endocannabinoids in aqueous humour of patients with or without diabetes. AEA, EC, OEA, PEA
97  2020 Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens. GI
98  2020 ENDOCANNABINOIDS RECEPTORS MEDIATED CENTRAL AND PERIPHERAL EFFECTS (REVIEW). AA, COX-2, ECs, PE, THC
99  2020 Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? AEA, ECs, NAEs, NAPEs
100  2020 Gene Expression Analysis of Astrocyte and Microglia Endocannabinoid Signaling during Autoimmune Demyelination. AEA, EAE, MS